Natural Living Newsletter
Mulberry Leaf Extract in Type 2 Diabetes
Introduction
The mulberry plant (Morus alba) is probably best known as the food for
silkworms, but it has also been highly regarded in traditional Chinese
and Japanese medicine. It has been shown to possess significant blood
sugar lowering effects in animal studies. Recently, human studies have
confirmed its benefits in both preventing and treating type 2 diabetes.
Mulberry contains an important compound known as moranoline (also known
as 1-deoxynojirimycin) that inhibits an enzyme in the intestinal tract
(alpha-glucosidase) that is involved in the digestion of carbohydrates.
Specifically, moranoline has been shown to prevent complex carbohydrates,
starches, maltose and sucrose (white sugar) from breaking down into highly
absorbable glucose molecules.
Mulberry extract reduces the glycemic effect
of sugar
Mulberry extract appears to exert considerably more benefits than just
inhibiting the breakdown and absorption of sugars. In one human study,
healthy volunteers received 0.8 and 1.2 g of a mulberry extract standardized
to contain 1.5% moranoline (corresponding to 12 and 18 mg of moranaline,
respectively) prior to receiving a 50 g dosage of sucrose.1
Before and 30-180 minutes after the mulberry/sucrose administration, plasma
glucose and insulin levels were determined. The results indicated that
while the mulberry extract reduced peak glucose levels by only 10%, peak
insulin levels were reduced by over 30% indicating increased insulin action
– a key goal in the treatment of insulin resistance, pre-diabetes,
and type 2 diabetes. At 60 minutes, blood glucose and insulin levels were
both more than 50% in the group getting the 1.2 g dose of mulberry extract
supplying 18 mg of moranoline. Again, this effect indicates significantly
enhanced insulin action.
Mulberry extract in the treatment of type
2 diabetes
Mulberry has been studied in the treatment of type 2 diabetes and the
results are excellent. In fact, in one of these studies the results are
superior to standard drug therapy.2 In the study, researchers
compared mulberry’s blood sugar lowering actions to the oral diabetes
drug glyburide which is also known as glibenclamide and Micronase. Patients
were given either mulberry dried leaves at a dose of 3 g/day or one tablet
of glyburide (5 mg/day) for four weeks. The results clearly show that
the fasting blood glucose concentrations were significantly lowered with
mulberry therapy, suggesting mulberry therapy is effective in controlling
diabetes. Compared to glyburide treatment, mulberry therapy significantly
reduced fasting blood glucose concentrations of diabetic patients by 27%.
However, in those subjects getting glyburide there was no significant
differences observed between pre- and post-treatment. Mulberry extract
was also superior to the approved drug in its ability to decrease hemoglobin
A1C – a marker of long-term blood sugar control.
While gliburide subjects enjoyed some minimal improvements in their blood
lipid profile, the changes were not statistically significant, except
for triglycerides, which fell by 10%. Mulberry patients, on the other
hand, experienced striking improvements across all lipid parameters, including
a dramatic drop in harmful LDL by 23% along with an 18% increase in highly
desirable HDL.
The research team also measured changes in lipid peroxidation in plasma,
urine, and red blood cell membranes. Lipid peroxidation occurs when lipids
are oxidized in the body, rendering them damaged and yet more harmful.
One of the goals of antioxidant therapy is to prevent lipid peroxidation
from occurring. In this study, plasma and urinary lipid peroxidation dropped
significantly in both groups, but the effect was stronger among mulberry
patients. Only mulberry significantly improved lipid peroxidation and
decreased cholesterol in red blood cell membranes. These results indicate
that mulberry not only reduces harmful lipids and apparently improves
sensitivity to glucose, but also possesses beneficial antioxidant properties.
Table 1 - Influence of mulberry
and glyburide treatments on blood glucose, glycosylated hemoglobin and
serum lipids of the patients with type 2 diabetes
| Glyburide | Mulberry | |||||
| Parameter | Before | After | Change (%) | Before | After | Change (%) |
| Fasting blood glucose (mg/dl) | 154.4 | 141.8 | -8 | 152.7 | 110.5 | -27% |
| A1C (%) | 12.5 | 12.4 | 0 | 12.5 | 11.2 | -10 |
| Cholesterol (mg/dl) | 190 | 182 | -4 | 193.7 | 170.3 | -12 |
| LDL-cholesterol (mg/dl) | 102.5 | 95.5 | -7 | 102.1 | 78.7 | -23 |
| HDL-cholesterol (mg/dl) | 49.8 | 51.3 | 3 | 50.1 | 59.2 | 18 |
| Triglycerides (mg/dl) | 199.5 | 180 | -10 | 200.4 | 168 | -16 |
| Free fatty acids (pmol/dl) | 589.8 | 580 | -2 | 590.1 | 520 | -12 |
Practical information
Mulberry leaf extract is available in a 30:1 concentrate standardized
to contain 2% moranoline content. The recommended dosage is 100 mg two
to three times daily. Mulberry leaf extract has no known toxicity, but
as the effects during pregnancy and lactation have not been sufficiently
evaluated, it is not recommended for use during these times unless directed
to do so by a physician. Since mulberry leaf extract improves blood sugar
control, individuals on oral hypoglycemic drugs for type 2 diabetes will
need to monitor blood sugar levels and work with their physician to adjust
drug dosage as needed.
© 2008 www.doctormurray.com